Physician profile
Ian David Kaye
NPI 1205128220
$42,132.13
in general payments reported to CMS, 2019-2025
15 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,339 · 2020: $3,331 · 2021: $3,815 · 2022: $7,102 · 2023: $8,629 · 2024: $455 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $15K · Consulting Fee: $11K · Food and Beverage: $813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $15,082.24 |
| Consulting Fee | $10,650.00 |
| Food and Beverage | $812.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $21,287.77 | 2019-2025 | Spira, Orthros |
| Nuvasive, INC. | $12,521.95 | 2020-2023 | Xlif, Pulse |
| Camber Spine Technologies LLC | $3,636.05 | 2019-2023 | |
| Medical Device Business Services, INC. | $2,340.00 | 2022 | |
| Stryker Corporation | $1,159.92 | 2019-2021 | |
| Nevro Corp. | $309.73 | 2024 | Senza |
| Intrinsic Therapeutics | $206.60 | 2022 | |
| Medtronic, INC. | $157.27 | 2025 | Inceptiv |
| Happe Spine | $145.15 | 2024 | Integrate-C |
| Globus Medical, INC. | $106.75 | 2025 | Senza |
| Spinal Simplicity, LLC | $97.38 | 2019 | |
| Depuy Synthes Sales INC. | $72.44 | 2019-2021 | |
| Acuity Surgical Devices, LLC | $55.79 | 2021-2022 | |
| Baxter Healthcare | $19.99 | 2019 | |
| Siemens Medical Solutions USA, INC. | $15.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$199,997.94 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Kaye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.